|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/39591 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 39/39575 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| C07K2317/41 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3955960 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20724633.1 |
| Date of filing the European patent application | 2020-04-16 | |
| (97) | Date of publication of the European application | 2022-02-23 |
| (45) | Date of publication and mention of the grant of the patent | 2025-01-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/028402 |
| Date | 2020-04-16 |
| (87) | Number | WO 2020/214748 |
| Date | 2020-10-22 |
| (30) | Number | Date | Country code |
| 201962835794 P | 2019-04-18 | US |
| (72) |
LEE, Peter Sung Keun , US
STROP, Pavel , US
RAJPAL, Arvind , US
GUDMUNDSSON, Olafur, S. , US
NANDI, Pradyot , US
|
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | IPILIMUMAB VARIANTS WITH ENHANCED SPECIFICITY FOR BINDING AT LOW PH |
| IPILIMUMAB VARIANTS WITH ENHANCED SPECIFICITY FOR BINDING AT LOW PH |